Astrocytic β2-adrenergic receptors: From physiology to pathology

Progress in Neurobiology

Volumn 91, Issue 3, 2010, Pages 189-199

  Laureys, Guy ^b   Clinckers, Ralph ^b   Gerlo, Sarah ^d   Spooren, Anneleen ^d   Wilczak, Nadine ^c   Kooijman, Ron ^b   Smolders, Ilse ^b   Michotte, Yvette ^b   De Keyser, Jacques ^a,c  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Alzheimer; Astrocytes; Beta adrenergic receptors; Hepatic encephalopathy; HIV encephalitis; Multiple sclerosis; Stroke

Indexed keywords

BETA ADRENERGIC RECEPTOR; GLYCOGEN; NEUROTROPHIC FACTOR; TRANSCRIPTION FACTOR; BETA 2 ADRENERGIC RECEPTOR;

ALZHEIMER DISEASE; ASTROCYTE; ASTROCYTOSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; GLYCOGEN METABOLISM; GLYCOGEN SYNTHESIS; HEPATIC ENCEPHALOPATHY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE CELL LESION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; STROKE; VIRUS ENCEPHALITIS; ANIMAL; BRAIN; BRAIN DISEASE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; BRAIN; BRAIN DISEASES; HUMANS; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 77952955641     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.01.011     Document Type: Review

References (221)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
2. Abe K., Saito H. Developmental changes in cyclic AMP-stimulated stellation of cultured rat cortical astrocytes. Jpn. J. Pharmacol. 1997, 75:433-438.
3. Akar C.A., Feinstein D.L. Modulation of inducible nitric oxide synthase expression by sumoylation. J. Neuroinflamm. 2009, 6:12.
4. Alexander G.M., Grothusen J.R., Gordon S.W., Schwartzman R.J. Intracerebral microdialysis study of glutamate reuptake in awake, behaving rats. Brain Res. 1997, 766:1-10.
5. Allaman I., Pellerin L., Magistretti P.J. Protein targeting to glycogen mRNA expression is stimulated by noradrenaline in mouse cortical astrocytes. Glia 2000, 30:382-391.
6. Allen S.J., Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin. Sci. (Lond.) 2006, 110:175-191.
7. Anlar B., Sullivan K.A., Feldman E.L. Insulin-like growth factor-I and central nervous system development. Horm. Metab. Res. 1999, 31:120-125.
8. Aoki C. Beta-adrenergic receptors: astrocytic localization in the adult visual cortex and their relation to catecholamine axon terminals as revealed by electron microscopic immunocytochemistry. J. Neurosci. 1992, 12:781-792.
9. Aoki C., Lubin M., Fenstemaker S. Columnar activity regulates astrocytic beta-adrenergic receptor-like immunoreactivity in V1 of adult monkeys. Vis. Neurosci. 1994, 11:179-187.
10. Aranami T., Yamamura T. Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol. Int. 2008, 57:115-120.
11. Aston-Jones G., Astier B., Ennis M. Inhibition of noradrenergic locus coeruleus neurons by C1 adrenergic cells in the rostral ventral medulla. Neuroscience 1992, 48:371-381.
12. Baeuerle P.A., Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988, 242:540-546.
13. Ballestas M.E., Benveniste E.N. Interleukin 1-beta- and tumor necrosis factor-alpha-mediated regulation of ICAM-1 gene expression in astrocytes requires protein kinase C activity. Glia 1995, 14:267-278.
14. Ballestas M.E., Benveniste E.N. Elevation of cyclic AMP levels in astrocytes antagonizes cytokine-induced adhesion molecule expression. J. Neurochem. 1997, 69:1438-1448.
15. Baltensperger K., Karoor V., Paul H., Ruoho A., Czech M.P., Malbon C.C. The beta-adrenergic receptor is a substrate for the insulin receptor tyrosine kinase. J. Biol. Chem. 1996, 271:1061-1064.
16. Bendek G., Hahn Z. Inhibition of 3H-thymidine incorporation into the DNA of developing rat brain by amphetamine treatment. Prog. Neuropsychopharmacol. 1979, 3:555-558.
17. Berberich-Siebelt F., Berberich I., Andrulis M., Santner-Nanan B., Jha M.K., Klein-Hessling S., Schimpl A., Serfling E. SUMOylation interferes with CCAAT/enhancer-binding protein beta-mediated c-myc repression, but not IL-4 activation in T cells. J. Immunol. 2006, 176:4843-4851.
18. Bernardo A., Patrizio M., Levi G., Petrucci T.C. Human immunodeficiency virus protein gp120 interferes with beta-adrenergic receptor-mediated protein phosphorylation in cultured rat cortical astrocytes. Cell. Mol. Neurobiol. 1994, 14:159-173.
19. Bernardo A., Levi G., Minghetti L. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur. J. Neurosci. 2000, 12:2215-2223.
20. Biber K., Pinto-Duarte A., Wittendorp M.C., Dolga A.M., Fernandes C.C., Von Frijtag Drabbe Kunzel J., Keijser J.N., de Vries R., Ijzerman A.P., Ribeiro J.A., et al. Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology 2008, 33:2237-2250.
21. Bondareff W., Mountjoy C.Q., Roth M., Rossor M.N., Iversen L.L., Reynolds G.P., Hauser D.L. Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1987, 1:256-262.
22. Brambilla R., Bracchi-Ricard V., Hu W.H., Frydel B., Bramwell A., Karmally S., Green E.J., Bethea J.R. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 2005, 202:145-156.
23. Brown G.C. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 2007, 35:1119-1121.
24. Brown A.M., Ransom B.R. Astrocyte glycogen and brain energy metabolism. Glia 2007, 55:1263-1271.
25. Brown A.M., Tekkok S.B., Ransom B.R. Glycogen regulation and functional role in mouse white matter. J. Physiol. 2003, 549:501-512.
26. Brown A.M., Sickmann H.M., Fosgerau K., Lund T.M., Schousboe A., Waagepetersen H.S., Ransom B.R. Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter. J. Neurosci. Res. 2005, 79:74-80.
27. Bruno V., Copani A., Besong G., Scoto G., Nicoletti F. Neuroprotective activity of chemokines against N-methyl-d-aspartate or beta-amyloid-induced toxicity in culture. Eur. J. Pharmacol. 2000, 399:117-121.
28. Cardinaux J.R., Magistretti P.J. Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolism. J. Neurosci. 1996, 16:919-929.
29. Carnevale D., De Simone R., Minghetti L. Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol. Disord. Drug Targets 2007, 6:388-397.
30. Cataldo A.M., Broadwell R.D. Cytochemical identification of cerebral glycogen and glucose-6-phosphatase activity under normal and experimental conditions. II. Choroid plexus and ependymal epithelia, endothelia and pericytes. J. Neurocytol. 1986, 15:511-524.
31. Chesik D., De Keyser J., Glazenburg L., Wilczak N. Insulin-like growth factor binding proteins: regulation in chronic active plaques in multiple sclerosis and functional analysis of glial cells. Eur. J. Neurosci. 2006, 24:1645-1652.
32. Chesik D., Wilczak N., De Keyser J. The insulin-like growth factor system in multiple sclerosis. Int. Rev. Neurobiol. 2007, 79:203-226.
33. Chesik D., Wilczak N., De Keyser J. IGF-1 regulates cAMP levels in astrocytes through a beta2-adrenergic receptor-dependant mechanism. Int. J. Med. Sci. 2008, 5:240-243.
34. Cohen Z., Molinatti G., Hamel E. Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J. Cereb. Blood Flow Metab. 1997, 17:894-904.
35. Colangelo A.M., Johnson P.F., Mocchetti I. Beta-adrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein delta. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10920-10925.
36. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 1995, 9:899-909.
37. Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J. Neurosci. 2000, 20:558-567.
38. Culmsee C., Semkova I., Krieglstein J. NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem. Int. 1999, 35:47-57.
39. Culmsee C., Stumm R.K., Schafer M.K., Weihe E., Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur. J. Pharmacol. 1999, 379:33-45.
40. Culmsee C., Junker V., Thal S., Kremers W., Maier S., Schneider H.J., Plesnila N., Krieglstein J. Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia. Eur. J. Pharmacol. 2007, 575:57-65.
41. Cummins C.J., Lust W.D., Passonneau J.V. Regulation of glycogenolysis in transformed astrocytes in vitro. J. Neurochem. 1983, 40:137-144.
42. Dabir D.V., Robinson M.B., Swanson E., Zhang B., Trojanowski J.Q., Lee V.M., Forman M.S. Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J. Neurosci. 2006, 26:644-654.
43. De Keyser J., Wilczak N., Leta R., Streetland C. Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 1999, 53:1628-1633.
44. De Keyser J., Wilczak N., Walter J.H., Zurbriggen A. Disappearance of beta2-adrenergic receptors on astrocytes in canine distemper encephalitis: possible implications for the pathogenesis of multiple sclerosis. Neuroreport 2001, 12:191-194.
45. De Keyser J., Zeinstra E., Wilczak N. Astrocytic beta2-adrenergic receptors and multiple sclerosis. Neurobiol. Dis. 2004, 15:331-339.
46. De Keyser J., Mostert J.P., Koch M.W. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci. 2008, 267:3-16.
47. De Keyser J., Steen C., Mostert J.P., Koch M.W. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J. Cereb. Blood Flow Metab. 2008, 28:1645-1651.
48. Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J.M., Gonzalez F.J., Fruchart J.C., Tedgui A., Haegeman G., Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 1999, 274:32048-32054.
49. Delgado M., Ganea D. Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo. J. Immunol. 2001, 167:966-975.
50. Denis-Donini S., Caprini A., Frassoni C., Grilli M. Members of the NF-kappaB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain. Brain Res. Dev. Brain Res. 2005, 154:81-89.
51. Deschepper C.F. Peptide receptors on astrocytes. Front. Neuroendocrinol. 1998, 19:20-46.
52. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20:649-688.
53. Dienel G.A., Ball K.K., Cruz N.F. A glycogen phosphorylase inhibitor selectively enhances local rates of glucose utilization in brain during sensory stimulation of conscious rats: implications for glycogen turnover. J. Neurochem. 2007, 102:466-478.
54. Eaton E.M., Sealy L. Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J. Biol. Chem. 2003, 278:33416-33421.
55. Eugenin E.A., D'Aversa T.G., Lopez L., Calderon T.M., Berman J.W. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J. Neurochem. 2003, 85:1299-1311.
56. Fahrig T. Receptor subtype involved and mechanism of norepinephrine-induced stimulation of glutamate uptake into primary cultures of rat brain astrocytes. Glia 1993, 7:212-218.
57. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28:138-145.
58. Farmer P., Pugin J. beta-adrenergic agonists exert their " anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L675-682.
59. Feinstein D.L. Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS-2 promoter activity. J. Neurochem. 1998, 70:1484-1496.
60. Feinstein D.L., Rozelman E. Norepinephrine suppresses l-arginine uptake in rat glial cells. Neurosci. Lett. 1997, 223:37-40.
61. Feinstein D.L., Galea E., Reis D.J. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J. Neurochem. 1993, 60:1945-1948.
62. Fernandez A.M., Fernandez S., Carrero P., Garcia-Garcia M., Torres-Aleman I. Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals. J. Neurosci. 2007, 27:8745-8756.
63. Fernandez S., Fernandez A.M., Lopez-Lopez C., Torres-Aleman I. Emerging roles of insulin-like growth factor-I in the adult brain. Growth Horm. IGF Res. 2007, 17:89-95.
64. Fillenz M., Lowry J.P., Boutelle M.G., Fray A.E. The role of astrocytes and noradrenaline in neuronal glucose metabolism. Acta Physiol. Scand. 1999, 167:275-284.
65. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 2002, 23:824-854.
66. Follesa P., Mocchetti I. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by beta-adrenergic receptor activation and adrenal steroids in rat central nervous system. Mol. Pharmacol. 1993, 43:132-138.
67. Fraser C.C. G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer. Int. Rev. Immunol. 2008, 27:320-350.
68. Frohman E.M., Vayuvegula B., Gupta S., van den Noort S. Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:1292-1296.
69. Frohman E.M., Vayuvegula B., van den Noort S., Gupta S. Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes. J. Neuroimmunol. 1988, 17:89-101.
70. Fukumoto H., Kakihana M., Suno M. Characterization of C6-10A glioma cells highly responsive to beta-adrenergic receptor agonist-induced NGF synthesis/secretion. Glia 1994, 12:151-160.
71. Gagelin C., Toru-Delbauffe D., Gavaret J.M., Pierre M. Effects of cyclic AMP on components of the cell cycle machinery regulating DNA synthesis in cultured astrocytes. J. Neurochem. 1999, 73:1799-1805.
72. Galea E., Feinstein D.L. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J. 1999, 13:2125-2137.
73. Gao N., Asamitsu K., Hibi Y., Ueno T., Okamoto T. AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65. J. Biol. Chem. 2008, 283:7834-7843.
74. Gavrilyuk V., Horvath P., Weinberg G., Feinstein D.L. A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J. Neurochem. 2001, 78:129-140.
75. Gavrilyuk V., Dello Russo C., Heneka M.T., Pelligrino D., Weinberg G., Feinstein D.L. Norepinephrine increases I kappa B alpha expression in astrocytes. J. Biol. Chem. 2002, 277:29662-29668.
76. Gavrilyuk V., Kalinin S., Hilbush B.S., Middlecamp A., McGuire S., Pelligrino D., Weinberg G., Feinstein D.L. Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties. J. Neurochem. 2005, 92:1140-1149.
77. Gerard N.P., Lu B., Liu P., Craig S., Fujiwara Y., Okinaga S., Gerard C. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J. Biol. Chem. 2005, 280:39677-39680.
78. Gharami K., Das S. Thyroid hormone-induced morphological differentiation and maturation of astrocytes are mediated through the beta-adrenergic receptor. J. Neurochem. 2000, 75:1962-1969.
79. Ghosh M., Das S. Increased beta(2)-adrenergic receptor activity by thyroid hormone possibly leads to differentiation and maturation of astrocytes in culture. Cell. Mol. Neurobiol. 2007, 27:1007-1021.
80. Gochenauer G.E., Robinson M.B. Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent L-[3H]glutamate transport and expression of both system xc(-) subunits. J. Neurochem. 2001, 78:276-286.
81. Gonzalez-Scarano F., Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 2005, 5:69-81.
82. Griffith R., Sutin J. Reactive astrocyte formation in vivo is regulated by noradrenergic axons. J. Comp. Neurol. 1996, 371:362-375.
83. Hadcock J.R., Port J.D., Gelman M.S., Malbon C.C. Cross-talk between tyrosine kinase and G-protein-linked receptors. Phosphorylation of beta 2-adrenergic receptors in response to insulin. J. Biol. Chem. 1992, 267:26017-26022.
84. Hansson E. Regulation of glutamine synthetase synthesis and activity by glucocorticoids and adrenoceptor activation in astroglial cells. Neurochem. Res. 1989, 14:585-587.
85. Hansson E., Ronnback L. Adrenergic receptor regulation of amino acid neurotransmitter uptake in astrocytes. Brain Res. Bull. 1992, 29:297-301.
86. Hayes V.Y., Isackson P.J., Fabrazzo M., Follesa P., Mocchetti I. Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: contrasting anatomical and cellular localization. Exp. Neurol. 1995, 132:33-41.
87. Heneka M.T., Klockgether T., Feinstein D.L. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J. Neurosci. 2000, 20:6862-6867.
88. Heneka M.T., Galea E., Gavriluyk V., Dumitrescu-Ozimek L., Daeschner J., O'Banion M.K., Weinberg G., Klockgether T., Feinstein D.L. Noradrenergic depletion potentiates beta-amyloid-induced cortical inflammation: implications for Alzheimer's disease. J. Neurosci. 2002, 22:2434-2442.
89. Heneka M.T., Ramanathan M., Jacobs A.H., Dumitrescu-Ozimek L., Bilkei-Gorzo A., Debeir T., Sastre M., Galldiks N., Zimmer A., Hoehn M., et al. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J. Neurosci. 2006, 26:1343-1354.
90. Hodges-Savola C., Rogers S.D., Ghilardi J.R., Timm D.R., Mantyh P.W. Beta-adrenergic receptors regulate astrogliosis and cell proliferation in the central nervous system in vivo. Glia 1996, 17:52-62.
91. Hu X.X., Goldmuntz E.A., Brosnan C.F. The effect of norepinephrine on endotoxin-mediated macrophage activation. J. Neuroimmunol. 1991, 31:35-42.
92. Huang R., Hertz L. Noradrenaline-induced stimulation of glutamine metabolism in primary cultures of astrocytes. J. Neurosci. Res. 1995, 41:677-683.
93. Igbavboa U., Johnson-Anuna L.N., Rossello X., Butterick T.A., Sun G.Y., Wood W.G. Amyloid beta-protein1-42 increases cAMP and apolipoprotein E levels which are inhibited by beta1 and beta2-adrenergic receptor antagonists in mouse primary astrocytes. Neuroscience 2006, 142:655-660.
94. Jalan R., Shawcross D., Davies N. The molecular pathogenesis of hepatic encephalopathy. Int. J. Biochem. Cell. Biol. 2003, 35:1175-1181.
95. Jiang C., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86.
96. Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A.M., Le Diguardher T., Khrestchatisky M., Rivera S. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur. J. Neurosci. 2003, 18:1507-1517.
97. Junker V., Becker A., Huhne R., Zembatov M., Ravati A., Culmsee C., Krieglstein J. Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection. Eur. J. Pharmacol. 2002, 446:25-36.
98. Juric D.M., Miklic S., Carman-Krzan M. Monoaminergic neuronal activity up-regulates BDNF synthesis in cultured neonatal rat astrocytes. Brain Res. 2006, 1108:54-62.
99. Karoor V., Malbon C.C. Insulin-like growth factor receptor-1 stimulates phosphorylation of the beta2-adrenergic receptor in vivo on sites distinct from those phosphorylated in response to insulin. J. Biol. Chem. 1996, 271:29347-29352.
100. Kenton L., Boon F., Cain D.P. Combined but not individual administration of beta-adrenergic and serotonergic antagonists impairs water maze acquisition in the rat. Neuropsychopharmacology 2008, 33:1298-1311.
101. Kernie S.G., Parada L.F. The molecular basis for understanding neurotrophins and their relevance to neurologic disease. Arch. Neurol. 2000, 57:654-657.
102. Kim J., Cantwell C.A., Johnson P.F., Pfarr C.M., Williams S.C. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J. Biol. Chem. 2002, 277:38037-38044.
103. Kimelberg H.K. Receptors on astrocytes-what possible functions?. Neurochem. Int. 1995, 26:27-40.
104. Klotz L., Sastre M., Kreutz A., Gavrilyuk V., Klockgether T., Feinstein D.L., Heneka M.T. Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons. J. Neurochem. 2003, 86:907-916.
105. Kobayashi K., Morita S., Sawada H., Mizuguchi T., Yamada K., Nagatsu I., Hata T., Watanabe Y., Fujita K., Nagatsu T. Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J. Biol. Chem. 1995, 270:27235-27243.
106. Kong E.K., Peng L., Chen Y., Yu A.C., Hertz L. Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration. Neurochem. Res. 2002, 27:113-120.
107. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 2009, 27:485-517.
108. Lauder J.M. Roles for neurotransmitters in development: possible interaction with drugs during the fetal and neonatal periods. Prog. Clin. Biol. Res. 1985, 163C:375-380.
109. Lazennec G., Canaple L., Saugy D., Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 2000, 14:1962-1975.
110. Le Prince G., Fages C., Rolland B., Nunez J., Tardy M. DBcAMP effect on the expression of GFAP and of its encoding mRNA in astroglial primary cultures. Glia 1991, 4:322-326.
111. Lee R.K., Araki W., Wurtman R.J. Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:5422-5426.
112. Lee S.Y., Kim H.J., Lee W.J., Joo S.H., Jeon S.J., Kim J.W., Kim H.S., Han S.H., Lee J., Park S.H., et al. Differential regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by the cyclic-AMP system in lipopolysaccharide-stimulated rat primary astrocytes. Neurochem. Res. 2008, 33:2324-2334.
113. Levi G., Patrizio M., Bernardo A., Petrucci T.C., Agresti C. Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:1541-1545.
114. Liskowsky D.R., Norenberg L.O., Norenberg M.D. Effect of ammonia on cyclic AMP production in primary astrocyte cultures. Brain Res. 1986, 386:386-388.
115. Liu Y.L., Jia W.G., Strosberg A.D., Cynader M. Morphology and distribution of neurons and glial cells expressing beta-adrenergic receptors in developing kitten visual cortex. Dev. Brain Res. 1992, 65:269-273.
116. Lizardi-Cervera J., Almeda P., Guevara L., Uribe M. Hepatic encephalopathy: a review. Ann. Hepatol. 2003, 2:122-130.
117. Madrigal J.L., Leza J.C., Polak P., Kalinin S., Feinstein D.L. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J. Neurosci. 2009, 29:263-267.
118. Maimone D., Cioni C., Rosa S., Macchia G., Aloisi F., Annunziata P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha. J. Neuroimmunol. 1993, 47:73-81.
119. Mantyh P.W., Rogers S.D., Allen C.J., Catton M.D., Ghilardi J.R., Levin L.A., Maggio J.E., Vigna S.R. Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human. J. Neurosci. 1995, 15:152-164.
120. Maolood N., Hardin-Pouzet H., Grange-Messent V. Matrix metalloproteinases MMP2 and MMP9 are upregulated by noradrenaline in the mouse neuroendocrine hypothalamus. Eur. J. Neurosci. 2008, 27:1143-1152.
121. Masters B.A., Werner H., Roberts C.T., LeRoith D., Raizada M.K. Developmental regulation of insulin-like growth factor-I-stimulated glucose transporter in rat brain astrocytes. Endocrinology 1991, 128:2548-2557.
122. McCarthy K.D., Prime J., Harmon T., Pollenz R. Receptor-mediated phosphorylation of astroglial intermediate filament proteins in cultured astroglia. J. Neurochem. 1985, 44:723-730.
123. Menendez Iglesias B., Cerase J., Ceracchini C., Levi G., Aloisi F. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents. J. Neuroimmunol. 1997, 72:83-93.
124. Mercier G., Lennon A.M., Renouf B., Dessouroux A., Ramauge M., Courtin F., Pierre M. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J. Mol. Neurosci. 2004, 24:207-216.
125. Michael L.F., Lazar M.A., Mendelson C.R. Peroxisome proliferator-activated receptor gamma1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes. Endocrinology 1997, 138:3695-3703.
126. Mohanakumar K.P., Mohanty S., Ganguly D.K. Neonatal treatment with 5-HT antiserum alters 5-HT metabolism and function in adult rats. Neuroreport 1995, 7:238-240.
127. Mostert J.P., Admiraal-Behloul F., Hoogduin J.M., Luyendijk J., Heersema D.J., van Buchem M.A., De Keyser J. Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study. J. Neurol. Neurosurg. Psychiatry 2008, 79:1027-1031.
128. Mostert J.P., Koch M.W., Heerings M., Heersema D.J., De Keyser J. Therapeutic potential of fluoxetine in neurological disorders. CNS Neurosci. Ther. 2008, 14:153-164.
129. Muir E.M., Adcock K.H., Morgenstern D.A., Clayton R., von Stillfried N., Rhodes K., Ellis C., Fawcett J.W., Rogers J.H. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res. Mol. Brain Res. 2002, 100:103-117.
130. Mun-Bryce S., Rosenberg G.A. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am. J. Physiol. 1998, 274:R1203-1211.
131. Mutinelli F., Vandevelde M., Griot C., Richard A. Astrocytic infection in canine distemper virus-induced demyelination. Acta Neuropathol. 1989, 77:333-335.
132. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R.M., Silva A.J., Kaczmarek L., Huntley G.W. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J. Neurosci. 2006, 26:1923-1934.
133. Nakamura A., Johns E.J., Imaizumi A., Abe T., Kohsaka T. Regulation of tumour necrosis factor and interleukin-6 gene transcription by beta2-adrenoceptor in the rat astrocytes. J. Neuroimmunol. 1998, 88:144-153.
134. Nath A., Schiess N., Venkatesan A., Rumbaugh J., Sacktor N., McArthur J. Evolution of HIV dementia with HIV infection. Int. Rev. Psychiatry 2008, 20:25-31.
135. Newman E.A. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci. 2003, 26:536-542.
136. Ni Y., Zhao X., Bao G., Zou L., Teng L., Wang Z., Song M., Xiong J., Bai Y., Pei G. Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. Nat. Med. 2006, 12:1390-1396.
137. Niino M., Kikuchi S., Miyagishi R., Fukazawa T., Yabe I., Tashiro K. An examination of the association between beta2 adrenergic receptor polymorphisms and multiple sclerosis. Mult. Scler. 2002, 8:475-478.
138. Nimmerjahn A. Astrocytes going live: advances and challenges. J. Physiol.-Lond. 2009, 587:1639-1647.
139. Nomura Y. NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci. 2001, 68:1695-1701.
140. Norenberg M.D. The role of astrocytes in hepatic encephalopathy. Neurochem. Pathol. 1987, 6:13-33.
141. Norris J.G., Benveniste E.N. Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J. Neuroimmunol. 1993, 45:137-145.
142. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343:938-952.
143. Ollivier V., Parry G.C., Cobb R.R., de Prost D., Mackman N. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 1996, 271:20828-20835.
144. Ouyang M., Zhang L., Zhu J.J., Schwede F., Thomas S.A. Epac signaling is required for hippocampus-dependent memory retrieval. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11993-11997.
145. Pahan K., Namboodiri A.M., Sheikh F.G., Smith B.T., Singh I. Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 1997, 272:7786-7791.
146. Paspalas C.D., Papadopoulos G.C. Ultrastructural relationships between noradrenergic nerve fibers and non-neuronal elements in the rat cerebral cortex. Glia 1996, 17:133-146.
147. Penkowa M., Camats J., Hadberg H., Quintana A., Rojas S., Giralt M., Molinero A., Campbell I.L., Hidalgo J. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide. J. Neurosci. Res. 2003, 73:481-496.
148. Podkletnova I., Alho H. Neonatal noradrenaline depletion prevents the transition of Bergmann glia in the developing cerebellum. J. Chem. Neuroanat. 1998, 14:167-173.
149. Porter J.T., McCarthy K.D. Astrocytic neurotransmitter receptors in situ and in vivo. Prog. Neurobiol. 1997, 51:439-455.
150. Rajaram S., Baylink D.J., Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 1997, 18:801-831.
151. Rangarajan S., Enserink J.M., Kuiperij H.B., de Rooij J., Price L.S., Schwede F., Bos J.L. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor. J. Cell. Biol. 2003, 160:487-493.
152. Ransom B.R., Fern R. Does astrocytic glycogen benefit axon function and survival in CNS white matter during glucose deprivation?. Glia 1997, 21:134-141.
153. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
154. Riva M.A., Molteni R., Lovati E., Fumagalli F., Rusnati M., Racagni G. Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor. Mol. Pharmacol. 1996, 49:699-706.
155. Riva M.A., Molteni R., Racagni G. Differential regulation of FGF-2 and FGFR-1 in rat cortical astrocytes by dexamethasone and isoproterenol. Brain Res. Mol. Brain Res. 1998, 57:38-45.
156. Rolls A., Shechter R., Schwartz M. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 2009, 10:235-241.
157. Rosenberg P.B., Mielke M.M., Tschanz J., Cook L., Corcoran C., Hayden K.M., Norton M., Rabins P.V., Green R.C., Welsh-Bohmer K.A., et al. Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. Am. J. Geriatr. Psychiatry 2008, 16:883-892.
158. Rougon G., Noble M., Mudge A.W. Neuropeptides modulate the beta-adrenergic response of purified astrocytes in vitro. Nature 1983, 305:715-717.
159. Russo V.C., Gluckman P.D., Feldman E.L., Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr. Rev. 2005, 26:916-943.
160. Sakisaka T., Takai Y. Cell adhesion molecules in the CNS. J. Cell. Sci. 2005, 118:5407-5410.
161. Salm A.K., McCarthy K.D. The evidence for astrocytes as a target for central noradrenergic activity: expression of adrenergic receptors. Brain Res. Bull. 1992, 29:265-275.
162. Schousboe A., Waagepetersen H.S. Role of astrocytes in glutamate homeostasis: implications for excitotoxicity. Neurotox. Res. 2005, 8:221-225.
163. Schwaninger M., Schofl C., Blume R., Rossig L., Knepel W. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol. 1995, 47:1112-1118.
164. Schwartz J.P., Nishiyama N., Wilson D., Taniwaki T. Receptor-mediated regulation of neuropeptide gene expression in astrocytes. Glia 1994, 11:185-190.
165. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 2006, 7:194-206.
166. Seki M., Tanaka T., Sakai Y., Fukuchi T., Abe H., Nawa H., Takei N. Muller cells as a source of brain-derived neurotrophic factor in the retina: noradrenaline upregulates brain-derived neurotrophic factor levels in cultured rat Muller cells. Neurochem. Res. 2005, 30:1163-1170.
167. Semkova I., Schilling M., Henrich-Noack P., Rami A., Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 1996, 717:44-54.
168. Serezani C.H., Ballinger M.N., Aronoff D.M., Peters-Golden M. Cyclic AMP: master regulator of innate immune cell function. Am. J. Respir. Cell. Mol. Biol. 2008, 39:127-132.
169. Shain W., Madelian V., Martin D.L., Kimelberg H.K., Perrone M., Lepore R. Activation of beta-adrenergic receptors stimulates release of an inhibitory transmitter from astrocytes. J. Neurochem. 1986, 46:1298-1303.
170. Shain W., Forman D.S., Madelian V., Turner J.N. Morphology of astroglial cells is controlled by beta-adrenergic receptors. J. Cell. Biol. 1987, 105:2307-2314.
171. Shao Y., Sutin J. Expression of adrenergic receptors in individual astrocytes and motor neurons isolated from the adult rat brain. Glia 1992, 6:108-117.
172. Shapiro S.D. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell. Biol. 1998, 10:602-608.
173. Sheng J., Yang S., Xu L., Wu C., Wu X., Li A., Yu Y., Ni H., Fukuda M., Zhou J. Bystin as a novel marker for reactive astrocytes in the adult rat brain following injury. Eur. J. Neurosci. 2004, 20:873-884.
174. Sijens P.E., Mostert J.P., Irwan R., Potze J.H., Oudkerk M., De Keyser J. Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging. Psychiatry Res. 2008, 164:274-282.
175. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
176. Sorg O., Magistretti P.J. Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes. Brain Res. 1991, 563:227-233.
177. Sorg O., Magistretti P.J. Vasoactive intestinal peptide and noradrenaline exert long-term control on glycogen levels in astrocytes: blockade by protein synthesis inhibition. J. Neurosci. 1992, 12:4923-4931.
178. Stein B., Cogswell P.C., Baldwin A.S. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 1993, 13:3964-3974.
179. Stout A.K., Raphael H.M., Kanterewicz B.I., Klann E., Reynolds I.J. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1998, 1:366-373.
180. Subbarao K.V., Hertz L. Effect of adrenergic agonists on glycogenolysis in primary cultures of astrocytes. Brain Res. 1990, 536:220-226.
181. Sun L., Wang X., Liu S., Wang Q., Wang J., Bennecib M., Gong C.X., Sengupta A., Grundke-Iqbal I., Iqbal K. Bilateral injection of isoproterenol into hippocampus induces Alzheimer-like hyperphosphorylation of tau and spatial memory deficit in rat. FEBS Lett. 2005, 579:251-258.
182. Sutin J., Griffith R. Beta-adrenergic receptor blockade suppresses glial scar formation. Exp. Neurol. 1993, 120:214-222.
183. Sutin J., Shao Y. Resting and reactive astrocytes express adrenergic receptors in the adult rat brain. Brain Res. Bull. 1992, 29:277-284.
184. Suzuki K., Ikegaya Y., Matsuura S., Kanai Y., Endou H., Matsuki N. Transient upregulation of the glial glutamate transporter GLAST in response to fibroblast growth factor, insulin-like growth factor and epidermal growth factor in cultured astrocytes. J. Cell. Sci. 2001, 114:3717-3725.
185. Swanson R.A. Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. Can. J. Physiol. Pharmacol. 1992, 70(Suppl.):S138-144.
186. Swanson R.A., Morton M.M., Sagar S.M., Sharp F.R. Sensory stimulation induces local cerebral glycogenolysis: demonstration by autoradiography. Neuroscience 1992, 51:451-461.
187. Szabo C., Hasko G., Zingarelli B., Nemeth Z.H., Salzman A.L., Kvetan V., Pastores S.M., Vizi E.S. Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 1997, 90:95-100.
188. Szanto A., Nagy L. The many faces of PPARgamma: anti-inflammatory by any means?. Immunobiology 2008, 213:789-803.
189. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 2002, 22:920-930.
190. Takahashi N., Tetsuka T., Uranishi H., Okamoto T. Inhibition of the NF-kappaB transcriptional activity by protein kinase A. Eur. J. Biochem. 2002, 269:4559-4565.
191. Takano T., Tian G.F., Peng W., Lou N., Libionka W., Han X., Nedergaard M. Astrocyte-mediated control of cerebral blood flow. Nat. Neurosci. 2006, 9:260-267.
192. Takuma K., Baba A., Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol. 2004, 72:111-127.
193. Tawfik V.L., Lacroix-Fralish M.L., Bercury K.K., Nutile-McMenemy N., Harris B.T., Deleo J.A. Induction of astrocyte differentiation by propentofylline increases glutamate transporter expression in vitro: heterogeneity of the quiescent phenotype. Glia 2006, 54:193-203.
194. Tokita Y., Keino H., Matsui F., Aono S., Ishiguro H., Higashiyama S., Oohira A. Regulation of neuregulin expression in the injured rat brain and cultured astrocytes. J. Neurosci. 2001, 21:1257-1264.
195. Torres-Aleman I., Naftolin F., Robbins R.J. Trophic effects of insulin-like growth factor-I on fetal rat hypothalamic cells in culture. Neuroscience 1990, 35:601-608.
196. Trejo J.L., Carro E., Lopez-Lopez C., Torres-Aleman I. Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm. IGF Res. 2004, 14(Suppl. A):S39-S43.
197. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008, 172:146-155.
198. Van Broeck B., Van Broeckhoven C., Kumar-Singh S. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches. Neurodegener. Dis. 2007, 4:349-365.
199. van de Stolpe A., van der Saag P.T. Intercellular adhesion molecule-1. J. Mol. Med. 1996, 74:13-33.
200. van Loo G., De Lorenzi R., Schmidt H., Huth M., Mildner A., Schmidt-Supprian M., Lassmann H., Prinz M.R., Pasparakis M. Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 2006, 7:954-961.
201. Vannucci S.J., Maher F., Simpson I.A. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 1997, 21:2-21.
202. Vlaeminck-Guillem V., Laudet V., Duterque-Coquillaud M. Negative cross-talk between nuclear receptors and transcription factors: implications in inflammation and oncogenesis. Med. Sci. (Paris) 2003, 19:1121-1127.
203. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6:626-640.
204. Wahli W., Braissant O., Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem. Biol. 1995, 2:261-266.
205. Walls A.B., Heimburger C.M., Bouman S.D., Schousboe A., Waagepetersen H.S. Robust glycogen shunt activity in astrocytes: effects of glutamatergic and adrenergic agents. Neuroscience 2009, 158:284-292.
206. Wang D.D., Bordey A. The astrocyte odyssey. Prog. Neurobiol. 2008, 86:342-367.
207. Wang Q.W., Rowan M.J., Anwyl R. Inhibition of LTP by beta-amyloid is prevented by activation of beta2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway. Neurobiol. Aging 2008.
208. Wang X.Q., Peng Y.P., Lu J.H., Cao B.B., Qiu Y.H. Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK. Neurosci. Lett. 2009, 450:122-126.
209. Wells G.M., Catlin G., Cossins J.A., Mangan M., Ward G.A., Miller K.M., Clements J.M. Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 1996, 18:332-340.
210. Wender R., Brown A.M., Fern R., Swanson R.A., Farrell K., Ransom B.R. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J. Neurosci. 2000, 20:6804-6810.
211. Whitaker-Azmitia P.M. Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol. Rev. 1991, 43:553-561.
212. Wilkins A., Scolding N. Protecting axons in multiple sclerosis. Mult. Scler. 2008, 14:1013-1025.
213. Willis S.A., Nisen P.D. Inhibition of lipopolysaccharide-induced IL-1 beta transcription by cyclic adenosine monophosphate in human astrocytic cells. J. Immunol. 1995, 154:1399-1406.
214. Woiciechowsky C., Schoning B., Stoltenburg-Didinger G., Stockhammer F., Volk H.D. Brain-IL-1 beta triggers astrogliosis through induction of IL-6: inhibition by propranolol and IL-10. Med. Sci. Monit. 2004, 10:BR325-330.
215. Wright J.W., Harding J.W. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Prog. Neurobiol. 2004, 72:263-293.
216. Yin K.J., Cirrito J.R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.F., Turk J., et al. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 2006, 26:10939-10948.
217. Yong V.W., Krekoski C.A., Forsyth P.A., Bell R., Edwards D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998, 21:75-80.
218. Yong V.W., Power C., Forsyth P., Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2001, 2:502-511.
219. Zeinstra E., Wilczak N., De Keyser J. [3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain. Neurosci. Lett. 2000, 289:75-77.
220. Zeinstra E.M., Wilczak N., Wilschut J.C., Glazenburg L., Chesik D., Kroese F.G., De Keyser J. 5HT4 agonists inhibit interferon-gamma-induced MHC class II and B7 costimulatory molecules expression on cultured astrocytes. J. Neuroimmunol. 2006, 179:191-195.
221. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997, 89:413-424.